Aileron continues to do what its founder always wanted — help entrepreneurs in the heady work of building and nurturing a business. This year Aileron celebrates its 30th anniversary, and Aileron ...

Selection of 1.2 mg/kg dose of ALRN-6924 with the goal to extend duration of cell cycle arrest and, thus, chemoprotection New primary endpoint that is more closely aligned with regulatory precedents ...

Aileron Therapeutics pulled a hard pivot in 2023, merging with Lung Therapeutics to gain a new pipeline and investor base. Now, the biotech has distanced itself from its premerger form by rebranding ...

AUSTIN, Texas, July 1, 2024 /PRNewswire/ -- Aileron Therapeutics, Inc. ("Aileron" or the "Company") (NASDAQ: ALRN), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines ...

WALTHAM, Mass., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Aileron Therapeutics, Inc. ("Aileron") (NASDAQ: ALRN), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address ...

Spyker Cars may not have impressed in its F1 venture, but it certainly has made up for it off the track. The exclusive sportscar-maker has kept true to its promise made in March at the Geneva Auto ...

Spyker is still very much in the process of building cars. More specifically, the Dutch performance marque still builds its wild machines that walk a fine line between modern rolling art and shapely ...

Acquisition includes multiple clinical stage, orphan pulmonary disease candidates, including LTI-03, a Caveolin-1-related peptide in development for the treatment of idiopathic pulmonary fibrosis (IPF ...

Aileron Therapeutics' Phase 1b trial of inhaled LTI-03 showed positive trends in seven out of eight IPF biomarkers. LTI-03 reduced SPD by 5% at 14 days, outperforming current IPF standard care's 4% ...

Located on a Bethel Twp. campus in Miami County, Aileron is 70,000-square-foot non-profit school for business leaders. Founded by Clay Mathile, former owner of the Iams Co., it was originally called ...